Found: 10
Select item for more details and to access through your institution.
The endoplasmic reticulum pool of Bcl-xL prevents cell death through IP3R-dependent calcium release.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02112-1
- By:
- Publication type:
- Article
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 9, p. 1, doi. 10.1038/s41419-023-06117-z
- By:
- Publication type:
- Article
Pharmacological targeting of the protein synthesis mTOR/4E- BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 6, p. 735, doi. 10.15252/emmm.201404346
- By:
- Publication type:
- Article
Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-021-27847-8
- By:
- Publication type:
- Article
Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-021-27847-8
- By:
- Publication type:
- Article
A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate.
- Published in:
- NAR Cancer, 2021, v. 3, n. 3, p. 1, doi. 10.1093/narcan/zcab032
- By:
- Publication type:
- Article
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022 , 14 , 4265.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4265, doi. 10.3390/cancers14174265
- By:
- Publication type:
- Article
Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4957, doi. 10.3390/cancers13194957
- By:
- Publication type:
- Article
Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2986, doi. 10.3390/cancers13122986
- By:
- Publication type:
- Article